Alexandre Le Vert

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

Alice Minhinnick, Iman Satti, Stephanie A. Harris et al. · Vaccine · 2016 · 43 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes

Judith del Campo, Andrés Pizzorno, Sophia Djebali et al. · npj Vaccines · 2019 · 40 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model

Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo et al. · Frontiers in Immunology · 2023 · 32 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza

Judith del Campo, Julien Bouley, Marion Chevandier et al. · Frontiers in Immunology · 2021 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

Isabel Leroux‐Roels, Gwenn Waerlop, Jessika Tourneur et al. · Frontiers in Immunology · 2022 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17